The stability of iron ascorbate solutions was investigated, under both anaerobic and aerobic conditions, with the Fez+ and Fe3+ indicators, respectively ferrozine and mimosine, at different pH values. The species present under the differing conditions were investigated by electron paramagnetic resonance (EPR) and Mossbauer spectroscopy and by gel-filtration chromatography. At physiological pH (6.8-7.4) iron ascorbate solutions rapidly form mononuclear chelatable Fe3+ species as reflected by indicator studies and EPR. Mossbauer spectroscopy fails to detect any Fez+ species. EPR studies show a time-dependent decrease in rhombic Fe3+, particularly in oxygenated buffers, consistent with a conversion to polynudear Fe. 0, uptake studies show that the conversion of Fez+ to Fe3+ in Fe-ascorbate solutions a t pH > 7.0 was accompanied by rapid 0, consumption but preceded depletion of ascorbate. Addition of high concentrations of mannitol (50-200 mM) reduces the 0, consumption and partly stabilizes the rapidly chelatable Fe form. Gel filtration studies show that the oxidation of Fe-ascorbate solutions at pH 7.4 is accompanied by an increase in the apparent relative molecular mass of the Fe, presumably due to Fe polymer formation. These studies indicate the inherent instability of Fe-ascorbate solutions above neutral pH and clearly have important implications in the use of ascorbate in studies of Fe physiology.
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Iron: Ascorbate solutions: Speciation of iron
Fe-containing media, incorporating both 0, and ascorbate, have been widely used in studies of intestinal Fe absorption (Hyde, 1957; Brown & Justus, 1958; Manis & Schachter, 1962; Pearson & Reich, 1965; Hopping & Ruliffson, 1966; Jacobs et al. 1966; Helbock & Saltman, 1967; Thomson and Valberg, 1971 ; Acheson & Schultz, 1972; Howard & Jacobs, 1972; Sheehan, 1976; Savin & Cook, 1978; Cox & O'Donnell, 1982; Johnson et al. 1983; Simpson et al. 1986 ). Ascorbate and/or other dietary reducing agents are present with Fe and 0, in the intestinal lumen. In addition, ascorbate is an ingredient of many pharmacological Fe preparations and experimental diets and is present in rodent bile (Conrad & Schade, 1968) and rodent and human gastric juice (Breidenbach ef al. 1952; Rathbone et a/. 1989) . Ascorbate is known to have a profound enhancing effect on Fe absorption as measured by several different techniques (Brise & Hallberg, 1962; Conrad & Schade, 1968; Forth & Rummel, 1973; Hungerford & Linder, 1983; Marx & Stiekman, 1985) . This effect has usually been attributed to a combination of reducing and chelating effects of ascorbate (Gorman & Clydesdale, 1983) . Reduction is believed to prevent inhibitory effects of Fe3+ ligands such as phytic acid and hydroxides while chelation is thought to maintain Fe in a soluble and, therefore, available form. Recently, it was suggested that separate mechanisms of intestinal absorption might exist for different IuminaI Fe species (Peters et af. 1988; Simpson et at. 1989; Simpson & Peters, 1990) .
We have recently investigated Fe species present in mouse stomach and duodenal lumen (Simpson & Peters, 1990) . Others have investigated the importance of luminal reduction of Fe for Fe absorption (Wien & Van Campen, 1991) . Attempts were made to relate the species observed to model Fe solutions, Fe-nitrilotriacetate (NTA) or Fe-ascorbate, as used in many studies of Fe absorption mechanisms. These studies also noted apparent instability of Fe-ascorbate solutions, not associated with Fe precipitation, at physiological pH. In the present paper we have further investigated and characterized the Fe species present in Fe-ascorbate solutions over a pH range relevant to Fe absorption in the small intestine. Knowledge of ageing and disposition of Fe in these solutions is essential for the interpretation of past and future studies of Fe absorption from Fe-ascorbate solutions as well as the understanding of dietary Fe chemistry in the intestinal lumen.
METHODS A N D M A T E R I A L S

Materials
FeSO,, L-ascorbic acid (sodium salt), HEPES, mannitol, ferrozine and mimosine were all obtained from Sigma Chemical Co. Ltd. FeCl,. 6H,O, NaCl and sodium acetate were Analar grade obtained from BDH Chemicals Ltd, Poole, Dorset. Sephadex G50 was from Pharmacia, 59FeC13 was from Amersham International (UK) and 57FeC1, was from The Isotope Separation Unit, AERE, Harwell, Oxon.
Spectrophotometric studies
Fe-ascorbate (1 : 20, v/v) solutions (100 pmol Fe/l, 2 mmol ascorbate/l), at pH 64-7.4 (20 mM-HEPES buffer containing 100 mmol NaC1/1 and 100 mmol mannitol/l) and at pH 4.1-5.5 (100 mmol acetate buffer/l) were prepared by mixing 10 mmol FeCl,/l in 10mmol HC1/1 or fresh 10mmol FeSO,/I in water and double strength HEPESmannitol-NaC1 buffer and were incubated at 37" for up to 60min. At various time intervals, portions were removed and mixed with an equal volume of either 2mmol ferrozine/l or 2 mmol mimosine/l and the absorbance (562 and 450 nm respectively) determined immediately in a Perkin Elmer 557 dual-beam spectrophotometer.
Electron paramagnetic resonance (EPR) spectroscopy X Band EPR spectra (9300 MHz, using 100 kHz field modulation) were obtained with a Varian E9 spectrometer or a Bruker ESP300 spectrometer. Samples were gas-cooled to about 100 K. Spectra were baseline-corrected by subtraction of a cavity spectrum or water-buffer under identical conditions. Spectrometer settings are indicated in individual figure legends.
Mossbauer spectroscopy
Spectra were recorded at 77 K using 90 % enriched 57FeCl,-ascorbate (1 : 20, v/v) solutions at pH 6.8 and 7.4, as described previously, in a conventional constant-acceleration spectrometer, using a 57C0 in Rh source.
I R O N S P E C I A T I O N I N A S C O R B A T E S O L U T I O N S
Gel-jiltratioiz analysis of Fe-ascorbate solutions
The apparent relative molecular mass of the species in fresh and aged Fe-ascorbate solutions was determined with a Sephadex G50 (10 x 125 mm) column, equilibrated and eluted with mannitol-NaCI-HEPES, pH 7.4 or pH 6.4 at 21". Fractions (1 ml) were collected and radioactivity measured for 59Fe in an LKB gamma-7000 counter. The column was calibrated with ferric-EDTA, vitamin B,,, aprotinin and cytochrome c.
I59
Rate of 0, consumption 0, consumption was measured with a Rank Pt/Ag electrode, with 0.6 V voltage applied across the half-cells. After calibration, 1.94 ml buffer (mannitol-NaC1-HEPES, pH 64-7.4) was saturated to 95 YO with 0, and 60 pl Fe-ascorbate (1 : 20, v/v; pH 64-7.4) added with a Hamilton syringe. The subsequent consumption of 0, was recorded as a function of time.
R E S U L T S
Visible spectroscopic studies
The reaction between the chelator ferrozine (which gives a strong absorbance (562 nm) with Fez+ but not Fe3+ (Gibbs, 1976) ) and FeC1, v/v) solutions shows an instantaneous formation of Fez+-ferrozine complex (Fig. 1) . This initial phase is followed by a slower formation of FeZt-ferrozine suggesting that the Fe in the Fe-ascorbate mixture is present in more than one species, and that these forms can be discriminated by their rate of delivery of Fe to ferrozine. As Fe-ascorbate solutions are allowed to age, the amount of Fe rapidly available for chelation by ferrozine declines. Rapidly-available Fe may be Fez+ or an easily-reduced Fe3+ complex (Simpson & Peters, 1990) , slowly available Fe may be a more slowly reducible Fe3+ species (Simpson & Peters, 1990) . Fig. 2 shows the extent of the initial, rapid phase as a function of incubation time of the Fe-ascorbate mixture at different pH, before addition of ferrozine. At pH > 7.0 there is a pronounced decline in this species suggesting that, with incubation, the Fe is converted to another less-available species. Equivalent results were obtained when 10 mM-FeSO, was substituted for FeC1, in the preparation of the mixtures. Fig. 3 shows that omitting NaCl or mannitol accelerates the ageing of the Fe-ascorbate mixture. Omission of mannitol had a particularly marked effect (Fig. 3 ). These and previously published results (Simpson & Peters, 1987) suggest that HEPES, mannitol, NaCl or ferrozine are not responsible for the ageing of the solutions. The pH dependence of the ferrozine-available Fez+, measured after 5 min, shows a third-order dependence on OHconcentration, suggesting that the formation of iron hydroxide may be important (Simpson & Peters, 1987) . Changing the ascorbate concentration (Fig. 4) at pH 7.4 indicates that a higher ascorbate concentration results in a higher end-point level of ferrozine-available Fe. Omission of ascorbate (fresh FeSO, solutions used as Fe source) resulted in complete disappearance of ferrozine-available Fe by approximately 30 min. The initial rate of loss of ferrozine-available Fe is similar to that with ascorbate present. However, the time-courses (as in Fig. 1 ) show no slowly ferrozine-available Fe.
Similar experiments to those shown in Fig. 1 , substituting the Fe3+ chelator mimosine for ferrozine, reveal quantitatively comparable observations, suggesting that Fez+ and Fe3+ are in rapid equilibrium in these solutions. Studies of the ferrozine-and mimosine-chelatable Fe in Fe-ascorbate solutions pre-incubated at pH values in the range 4.1-5.5 showed that Fe remains 100 YO ferrozine-available at pH 4 5 and 5.5 as well as at pH 6.8. Fe rapidly available to mimosine, however, decreases from 100% at pH 6.8 to 0 % at pH 4.5, indicating a change in the nature of the readily chelatable Fe, from Fe in equilibrium between oxidation states Fez+ and Fe3+, to Fe in oxidation state Fez+ only. Below pH 4.5, FeC1,-ascorbate mixtures were prepared and at preincubation time t 0, prewarmed (37') buffer solutions were added to give a solution of 100 pmol Fe/l, 2 mmol sodium ascorbate/l, 0.1 mol mannitol/l, 20 mmol HEPES/I, pH 7.4 (air equilibrated). After various preincubation times at 37" (as indicated), 400 pl of the mixture was added to 400 pl ferrozine (2 mmol/l) and absorbance (A,,, ", , , ) recording commenced. For details of procedures, see p. 158.
Fez+ and Fe3+ can be completely distinguished by the two chelators; above pH 5.9, they are indistinguishable on the time-scale of this method.
Gel jiltration
Studies of fresh FeC1,-ascorbate (1 : 20, v/v) solutions at pH 7.4 and solutions at pH 7.4 incubated at 37" for 1 h (Fig. 5) show that the ageing of Fe-ascorbate solutions at pH 7.4 involves an apparent increase in the relative molecular mass of the Fe-containing species from approximately 500 to 1500. The lower recovery of Fe at short incubation periods may be due to binding of FeS+ ions to the multiple OH-groups on the column matrix or to trace amounts of acid groups which are present in Sephadex columns. Fresh solutions prepared at pH 6.4 show similar apparent relative molecular masses of those of fresh solutions at pH 7.4.
EPR spectra
FeC1,-ascorbate (1 : 20, v/v) solutions show that rhombic Fe3+ is present in these solutions as indicated by the geff 4.3 signal (Fig. 6) . Studies of spectra of a variety of Fe3+ complexes (NTA, EDTA, citrate, albumin, hydroxypyridinone complexes, transferrin and ferrioxamine) revealed geff 4.3 signals with varying line shapes. Double integration of these spectra showed a constant relationship between peak area and complex concentration for these many complexes, provided that chelator was present in excess. Peak height could also be used as an estimate of concentration where line shape variations were negligible. . Gel filtration analysis of iron in Fe-ascorbate mixtures. 59Fe-ascorbate mixture, 0.5 ml, was prepared as in Fig. 1 except that 59FeC1, in 10 mmol HCI/1 was mixed with FeCI, before addition of ascorbate, and was applied to a Sephadex G50 column equilibrated and eluted as described on p. 159. Fe-ascorbate solutions were preincubated at pH 7.4 for 4.5 min (A) or for 2 h (m). 59Fe recoveries from the column were 78 and 115%, respectively. Close examination of the spectra from Fe-ascorbate mixtures revealed only minor line shape changes during incubations such as those shown in Fig. 6. Fig. 7 shows how the peakto-peak height of this signal varies with period of incubation in a variety of Fe-ascorbate mixtures and incubation conditions. This is presumed to reflect changes in the concentration of rhombic Fe in oxidation state Fe3+ within the mixtures.
An estimate of the proportion of rhombic Fe in oxidation state Fe3+ can be made by comparing g,,, 4.3 peak heights with the signal from a standard solution of FeNTA,, and this indicated that the maximal peak height observed (pH 6.8 after 1 h incubation with air present) represented approximately 66% of total Fe. A similar value is obtained if the double integral of the gel, 4.3 signal is compared with the double integral of the other mononuclear Fe3+ standards (transferrin, mimosine). The decline in signal (pH 7.0-7.4) indicates either reduction to Fe2+, or formation of an Fe3+ polymeric species with strong coupling between the centres (Weir et al. 1985) . The observation that the decline corresponds with Fe being no longer available for rapid chelation by ferrozine suggests that the latter possibility is correct. At pH 6.8, steady formation of rhombic Fe3+ is observed. A similar study of Fe-ascorbate solutions at pH 7.4 and 6.8, but using degassed solutions incubated under N,, shows a marked decrease in the size of the g,,, 4.3 peak; presumably the Fe remains as Fez+ under these conditions. Subsequent exposure to air of solutions incubated at 37" for 1 h resulted in an increase in the peak of the signals to a value equivalent to that observed without N,. EPR of Fe-ascorbate in HEPES buffer lacking mannitol at pH 7.4 or 6.8 revealed only a small geff 4.3 peak, compared with those shown in Fig. 6 , even at 1 min after preparation (values not shown).
Mossbauer spectroscopy
The 77 K Mossbauer spectra of 57Fe-a~c~rbate solutions, prepared with 90 %-enriched 57Fe, and incubated for 1 h at pH 6.8 and 7.4 are shown in Fig. 8 . The spectra have a relatively poor signa1:noise value, as a result of the low Fe concentration. Both spectra are quadrupole split doublets and have been computer-fitted to obtain the Mossbauer variables. The fitted values of these variables are the same, within experimental error, for both samples, being 0.70 (SE 0.05) mm/s for the quadrupole splitting and 0.46 (SE 0.03) mm/s for the chemical shift. These variables indicate that the Fe is Fe3+ and are consistent with oxide or hydroxide ligands. There is no evidence for the presence of any significant Fe2+ component, which would show a much larger quadrupole splitting.
0, consumption studies
The initial rate of consumption of 0, by (1 : 20, v/v) FeS0,-ascorbate solutions declines markedly with decrease in pH from 7.4 to 6.4 (Fig. 9) . Experiments in which FeSO, was varied show an increase in the rate of consumption with increased FeSO, ( 0 4 0 0~~) concentration at constant (2 mM) ascorbate concentration, and similarly for varying ascorbate (&lo mM) concentrations at constant FeSO, (100 PM) concentration. Increase in either Fe or ascorbate concentrations both lead to an increase in the initial rate of 0, consumption, suggesting that an Fe-ascorbate complex is responsible. This is consistent with previous studies at low pH (Taqui Khan & Martell, 1967) . The rate of 0, consumption Velocity (mrnls) Fig. 8 . The 77 K Mossbauer spectra of 57Fe-ascorbate solutions prepared as described in Fig. 1 at pH 6.8 and 7.4. Incubation was for 1 h at 37", then samples were frozen for analysis. . Oxygen consumption by iron-ascorbate solutions. media were prepared, incubated at 37" and initial rate of 0, consumption measured as described on pp. 158-159. Medium pH was varied and determined in solutions after 0, consumption determination; Fe concentration was 100 ,umol/l, ascorbate 2 mmol/l. suggests that ascorbate depletion is not responsible for the Fe oxidation for short incubation periods (up to 10-20 min). The addition of superoxide dismutase (EC 1.15.1.1) appears to have little effect on 0, consumption. Decreasing the initial degree of 0, saturation of the solutions decreases the consumption rate, but this does not appear to be a first-order effect, as was previously observed (Taqui Khan & Martell, 1967) . Increasing the mannitol concentration (50-200 mM) results in a decrease in the rate of consumption, which might suggest that a free radical intermediate is involved in the reaction, although mannitol may also act by binding to the Fe.
D I S C U S S I O N
Iron species in Fe-ascorbate-0, mixtures Ascorbic acid is widely used in Fe absorption studies because it is a physiological Fe reductant-chelator and it is effective at maintaining Fe in a soluble and bioavailable form (Conrad & Schade, 1968) . We have concerned ourselves with changes in Fe speciation after an acid Fe-ascorbate mixture (presumed to contain Fez+ ions) is neutralized with buffer to pH values in the range 6.8-7.4. This represents a model for changes occurring in the proximal regions of the small intestine and also represents changes occurring after preparation of Fe-ascorbate solutions for in vitro studies. Thermodynamic considerations show that the reduction of Fe3+ to Fe2+ by ascorbic acid is favoured below pH values of approximately 6 but not at pH 7 or greater (Hungerford & Linder, 1983; Schneider, 1987) , and consideration of Fe-ascorbate as an Fe2+-ascorbate complex is unsatisfactory at neutral pH (Plug et al. 1984 ). Unfortunately we cannot think of Fe-ascorbate mixtures in terms of an ascorbate-dehydroascorbate couple because the dehydroascorbate ring opens irreversibly and is, therefore, not in equilibrium with its precursor (Dryhurst et af. 1982) . Understanding the species present in Fe-ascorbate mixtures is, therefore, not possible from thermodynamic considerations alone.
Our experiments, based on kinetics of reaction with an Fe2+ chelator (ferrozine) (Simpson & Peters, 1990) , have indicated that incubation for up to 60min in buffered solutions (pH 6.8-7.4) causes significant changes in the nature of the Fe such that the Fez+ concentration diminishes, the Fe being progressively converted to ferric species which are re-reduced on addition of the strong Fez+ chelator, ferrozine. The loss is slow or negligible at pH 7 or below but is rapid and extensive at pH 7.2 or above. Rates of 0, consumption show that in oxygenated solutions, as used frequently in in vitro studies of Fe absorption, depletion of ascorbate would only be a significant factor in longer incubations (approximately 1 h).
Chloride and mannitol are often used in physiological media to satisfy osmotic requirements of cells. These ligands are likely to coordinate and stabilize the Fe in its ferric form. It would appear that such Fe is still ferrozine-available, however. In the absence of chloride and of mannitol, the rate at which Fe converts to some unavailable form accelerates markedly. Likewise, the presence of ascorbate partly protects from the loss of ferrozine-available Fe.
In positive attempts to comment on the forms of Fe present in these complex solutions we have performed some gel filtration and some spectroscopic measurements. The former give a clear indication that the molecular size of one form of Fe present increases with the passage of time while the latter indicate the presence of Fe3+ and the absence of Fez+. The rhombic EPR signal at g,,, 4.3 is characteristic of monomeric high-spin Fe" (Gibson, 1980) . Note, however, that it represents only a proportion of the Fe present and that its behaviour parallels that of the ferrozine-available Fe at pH 7.4. At pH 6.8 this parallelism is not present and it would appear that some form of Fe other than that represented by the
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EPR is also ferrozine-available. The Fe seen by the Mossbauer experiment is also Fe3+, but is not variable with pH. This is consistent with the fact that the Mossbauer spectrum results from high-spin Fe3+ atoms in both cases, with the coupling which affects the EPR spectrum having essentially no effect on the Mossbauer spectrum. Thus, our studies suggest that ferric ascorbate is stable as a mononuclear complex at pH 6.8 or less but at higher pH polynuclear species of limited size are rapidly formed. The data presented in the present paper demonstrate that Fe3+ is a major Fe species in Fe-ascorbate mixtures at neutral pH values. The demonstration of Fez+ in such mixtures by addition of a powerful Fez+ chelator is misleading unless the kinetics of formation of the Fe2+echelator complex are taken into account.
Implications for previous studies of intestinal Fe absorption
These investigations of iron ascorbate solutions were prompted by our previous work into the mechanism of mucosal Fe uptake using in vitro systems. We had attempted to interpret those studies on the assumption that Fez+ ions are the principle Fe species in Fe-ascorbate solutions. Studies of liposome Fe uptake had, however, demonstrated ageing of Fe-ascorbate solutions (Simpson & Peters, 1987 Simpson et af. 1989 ). This similarity in uptake by tissue incubated in vitro may be contrasted with differences in uptake seen with Fe-ascorbate compared with Fe-NTA solutions incubated with brush-border membrane preparations or tied-off intestinal segments in vivo. We originally suggested that these differences could be due to differences in Fe valency (Simpson et al. 1986 ). This suggestion was clearly premature and a better explanation would be that the differences arise from differences in stability of Fe3+ complexes (Simpson et al. 1989 ). The fact that in vitro intestine sees Fe-ascorbate differently from in vivo intestine or isolated brush-border membrane vesicles may be attributable to the use of freshly neutralized Fe-ascorbate in the latter experiments (Simpson et al. 1986 ), while the in vitro studies employed somewhat aged, 0,-bubbled Fe-ascorbate solutions.
It is more difficult to re-interpret studies with Fe-ascorbate by other groups of workers as the age of the solutions was not controlled. It is tempting to suggest, however, that some of the contradictory results reported (e.g. the failure of Sheehan (1976) to demonstrate regulated uptake, in contrast to other workers) may have been due to differences in the preparation and pretreatment of the Fe-ascorbate mixtures, leading to different 59Fe species being present during the experiments.
Some studies supplied evidence for persistence of significant Fez+ ions in long periods of incubation (Rulifsson & Hopping, 1963 ). The present work shows that such evidence is misleading due to conversion of Fe3+ to Fez+ after addition of an Fe'+ chelator. Given a lack of special attempts to use short incubation periods and freshly neutralized solutions (as used in our own membrane studies), the Fe present in those studies probably was predominantly small polynuclear Fe3+. The findings suggest, therefore, that small polynuclear Fe species are available for uptake by intestinal mucosa, perhaps by reductive release of Fez+ ions at the brush-border membrane, as has been proposed recently (Raja et al. 1992 ). This latter suggestion would seem confusing, given the presence of ascorbate, but our work shows clearly that, at pH > 7.0, ascorbate is not an effective reducing agent for Fe3+ (unless a powerful Fez+ chelator is present). This finding disagrees with the observations of Gorman & Clydesdale (1983) but agrees with the work of Hungerford & Linder (1983) and Schneider (1987) .
Implications for Fe availability from foods and pharmaceuticals
Ascorbate is very well known for its promotion of Fe absorption from foods and pharmaceutical Fe preparations (Baynes & Bothwell, 1990) . The attribution of this effect to chelation and solubilization of Fe is supported by our work, as is the reduction of Fe3+ to Fe2+ at the low pH of the stomach. Many foods that contain ascorbate also have lower pH values (e.g. fruit juices), therefore Fez+ may be expected to be stabilized by ascorbate, as observed by Nojeim & Clydesdale (1981) . The present work suggests that rapid reoxidation of Fez+ to Fe3+ occurs on neutralization, even in the presence of ascorbate, at the ascorbate: Fe values often seen in foods and pharmaceuticals (< 20: 1). The detailed kinetics of Fez+ oxidation could not be investigated at pH > 7.0 due to the rapidity of the process. In foods, however, other stronger reducing agents may be present (e.g. cysteine) and these may be able to maintain Fez+ in the intestinal lumen (Wein & Van Campen, 1991) . 0, concentrations may also be low in the gastrointestinal lumen. Further work is needed to determine whether Fez+ really persists in the intestinal lumen during digestion and absorption, although earlier studies (Simpson & Peters, 1990) have provided evidence that oxidation of Fe2+ to Fe3+ accompanies the neutralization of stomach contents in the duodenal lumen.
Conclusions
When 0, is present, Fe in ascorbate mixtures remains rapidly chelatable only at pH < 7.0. Fe in such mixtures is predominantly FeS+ at physiological pH when 0, is present. C.D. was supported by a SERC Research Studentship and C.E.C. by a King's College Research Fellowship.
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